Cargando…

Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes

Receptors for prostaglandin E2 or histamine were measured on subpopulations of human lymphocytes, using the cyclic AMP increase after exposure to prostaglandin or histamine as an indicator for the presence of receptors. The cyclic AMP response to prostaglandin E2 was similar in unfractionated lympho...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1979
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2185694/
https://www.ncbi.nlm.nih.gov/pubmed/227981
_version_ 1782145800021737472
collection PubMed
description Receptors for prostaglandin E2 or histamine were measured on subpopulations of human lymphocytes, using the cyclic AMP increase after exposure to prostaglandin or histamine as an indicator for the presence of receptors. The cyclic AMP response to prostaglandin E2 was similar in unfractionated lymphocytes and the T-enriched and T-depleted fractions. Within the T-enriched population, T cells bearing a receptor for the Fc portion of IgG (T gamma-cells) had a 27.4-fold rise in cyclic AMP after exposure to prostaglandin E2, whereas the remaining T cells (non-T gamma cells) had a fourfold increase. It would appear that prostaglandin receptors are concentrated on a small subfraction of T gamma cells, comprising approximately 15% of the T-cell population. The cyclic AMP response to histamine was less than twofold in all lymphocyte fractions.
format Text
id pubmed-2185694
institution National Center for Biotechnology Information
language English
publishDate 1979
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21856942008-04-17 Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes J Exp Med Articles Receptors for prostaglandin E2 or histamine were measured on subpopulations of human lymphocytes, using the cyclic AMP increase after exposure to prostaglandin or histamine as an indicator for the presence of receptors. The cyclic AMP response to prostaglandin E2 was similar in unfractionated lymphocytes and the T-enriched and T-depleted fractions. Within the T-enriched population, T cells bearing a receptor for the Fc portion of IgG (T gamma-cells) had a 27.4-fold rise in cyclic AMP after exposure to prostaglandin E2, whereas the remaining T cells (non-T gamma cells) had a fourfold increase. It would appear that prostaglandin receptors are concentrated on a small subfraction of T gamma cells, comprising approximately 15% of the T-cell population. The cyclic AMP response to histamine was less than twofold in all lymphocyte fractions. The Rockefeller University Press 1979-11-01 /pmc/articles/PMC2185694/ /pubmed/227981 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes
title Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes
title_full Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes
title_fullStr Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes
title_full_unstemmed Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes
title_short Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes
title_sort cyclic adenosine monophosphate response to prostaglandin e2 on subpopulations of human lymphocytes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2185694/
https://www.ncbi.nlm.nih.gov/pubmed/227981